Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis
{{output}}
Interferon beta (IFNβ) reduces disease burden in relapsing-remitting multiple sclerosis (MS) patients. In this study, IFNβ-1b-treated MS patient gene expression profiles and biological knowledgebases were integrated to study IFNβ's pleiotropic mechanisms of... ...
